Impaired HDL function in obese adolescents: Impact of lifestyle intervention and bariatric surgery

Obesity

Volumn 21, Issue 12, 2013, Pages

  Matsuo, Yae ^a,b,c   Oberbach, Andreas ^d   Till, Holger ^d   Inge, Thomas H ^e   Wabitsch, Martin ^f   Moss, Anja ^f   Jehmlich, Nico ^g   Völker, Uwe ^g   Müller, Ulrike ^a   Siegfried, Wolfgang ^h   Kanesawa, Norio ^b   Kurabayashi, Masahiko ^c   Schuler, Gerhard ^a   Linke, Axel ^a   Adams, Volker ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b NATIONAL HOSPITAL ORGANIZATION TAKASAKI GENERAL MEDICAL CENTER   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g UNIVERSITY OF GREIFSWALD   (Germany)

^h Obesity Center Insula   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; APOLIPOPROTEIN; APOLIPOPROTEIN F; CLUSTERIN; CYSTEINE DIOXYGENASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; MICROSOMAL AMINOPEPTIDASE; PHOSPHOLIPID TRANSFER PROTEIN; PRENYLCYSTEINE OXIDASE 1; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 3; PROTEOME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BARIATRIC SURGERY; BIOCHEMICAL COMPOSITION; BODY MASS; BYPASS SURGERY; CELL STIMULATION; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; OBESITY; OUTCOME ASSESSMENT; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEOMICS; ROUX Y ANASTOMOSIS; SCHOOL CHILD; WEIGHT REDUCTION;

ADOLESCENT; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; ENDOTHELIAL CELLS; ENDOTHELIUM; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HEALTHY VOLUNTEERS; HUMANS; LIFE STYLE; MALE; NITRIC OXIDE SYNTHASE TYPE III; PEDIATRIC OBESITY; PHOSPHORYLATION; PROTEIN KINASE C BETA; PROTEOME; YOUNG ADULT;

EID: 84889668100     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20538     Document Type: Article

References (39)

1. Wang Y, Lobstein T,. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006; 1: 11-25.
2. Hubert HB, Feinleib M, McNamara PM, Castelli WP,. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
3. Baker JL, Olsen LW, Sorensen TIA,. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 2329-2337.
4. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC,. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010; 362: 485-493.
5. Berenson GS,. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: The Bogalusa Heart Study. Am J Cardiol 2002; 90: L3-L7.
6. Gonzalez MA, Selwyn AP,. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003; 115: 99S-106S.
7. Korkmaz H, Onalan O,. Evaluation of endothelial dysfunction: flow-mediated dilation. Endothelium 2008; 15: 157-163.
8. Di Angelantonio E,. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000.
9. Yuhanna IS, Zhu Y, Cox BE, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 2001; 7: 853-857.
10. Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N,. HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis. Cell Metab 2008; 7: 365-375.
11. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ,. The metabolism and anti-atherogenic properties of HDL. J Lipid Res 2009; 50: S195-S200.
12. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM,. Antiinflammatory properties of HDL. Circ Res 2004; 95: 764-772.
13. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM,. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011; 8: 222-232.
14. Sorrentino SA, Besler C, Rohrer L, et al. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release Niacin therapy. Circulation 2010; 121: 110-122.
15. Besler C, Heinrich K, Rohrer L, et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 2011; 121: 2693-2708.
16. Charakida M, Besler C, Batuca JR, et al. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA 2009; 302: 1210-1217.
17. Duffy D, Rader DJ,. Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 2009; 6: 455-463.
18. Walther C, Gaede L, Adams V, et al. Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: A prospective randomized trial. Circulation 2009; 120: 2251-2259.
19. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004; 114: 217-223.
20. Mangé A, Goux A, Badiou S, et al. HDL proteome in hemodialysis patients: A quantitative nanoflow liquid chromatography-tandem mass spectrometry approach. PLoS One 2012; 7: e34107.
21. Alwaili K, Bailey D, Awan Z, et al. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta 2012; 1821: 405-415.
22. Khalid M,. The role of nitric oxide in cardiovascular diseases. Mol Aspect Med 2005; 26: 33-65.
23. Schächinger V, Britten MB, Zeiher A,. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
24. Monostori P, Baráth A, Fazekas I, et al. Microvascular reactivity in lean, overweight, and obese hypertensive adolescents. Eur J Pediatr 2010; 169: 1369-1374.
25. Schlager O, Willfort-Ehringer A, Hammer A, et al. Microvascular function is impaired in children with morbid obesity. Vasc Med 2011; 16: 97-102.
26. Montero D, Walther G, Perez-Martin A, Roche E, Vinet A,. Endothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: Markers and effect of lifestyle intervention. Obes Rev 2012; 13: 441-455.
27. Landgraf K, Friebe D, Ullrich T, et al. Chemerin as a Mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 2012; 97: E556-E564.
28. Crocker MK, Yanovski JA,. Pediatric Obesity: Etiology and Treatment. Pediatr Clin North Am 2011; 58: 1217-1240.
29. Vidal J,. Updated review on the benefits of weight loss. Int J Obes Relat Metab Disord 2002; 26: S25-S28.
30. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents. Circulation 2005; 111: 1999-2012.
31. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. JAMA 2004; 292: 1724-1737.
32. Roberts CK, Chen AK, Barnard RJ,. Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 2007; 191: 98-106.
33. Nerla R, Tarzia P, Sestito A, et al. Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvascular function. Nutr Metab Cardiovasc Dis 2012; 22: 626-634.
34. Kelishadi R, Malekahmadi M, Hashemipour M, et al. Can a Trial of Motivational lifestyle counseling be effective for controlling childhood obesity and the associated cardiometabolic risk factors? Pediatr Neonatol 2012; 53: 90-97.
35. Beltaifa L, Chaouachi A, Zérifi R, et al. Walk-run transition speed training as an efficient exercise adjunct to dietary restriction in the management of obesity: A prospective intervention pilot study. Obes Facts 2011; 4: 45-52.
36. Roberts CK, Ng C, Hama S, Eliseo AJ, Barnard RJ,. Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J Appl Physiol 2006; 101: 1727-1732.
37. Chinchilla P, Xiao L, Kazanietz MG, Riobo NA,. Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways. Cell Cycle 2010; 9: 570-579.
38. Dyer MA, Farrington SM, Mohn D, Munday JR, Baron MH,. Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 2001; 128: 1717-1730.
39. Abuharbeid S, Czubayko F, Aigner A,. The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol 2006; 38: 1463-1468.